Edition:
United States

Immune Pharmaceuticals Inc (IMNP.OQ)

IMNP.OQ on NASDAQ Stock Exchange Capital Market

0.37USD
23 Feb 2018
Change (% chg)

$-0.00 (-0.99%)
Prev Close
$0.37
Open
$0.38
Day's High
$0.38
Day's Low
$0.36
Volume
94,417
Avg. Vol
219,048
52-wk High
$5.02
52-wk Low
$0.33

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.534
Jun '17 0.00 -0.500
Mar '17 0.00 -0.427
FY 2016 Dec '16 0.00 -1.538
Sep '16 0.00 -3.139
Jun '16 0.00 -2.659
Mar '16 0.00 -3.486
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Earnings (per share)
Quarter Ending Mar-18 1 -0.11 -0.11 -0.11 --
Quarter Ending Jun-18 1 -0.12 -0.12 -0.12 --
Year Ending Dec-18 1 -0.43 -0.43 -0.43 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.96 33.62
P/E High - Last 5 Yrs. -- 40.47 46.17
P/E Low - Last 5 Yrs. -- 23.33 24.19
Beta 1.72 0.81 0.81
Price to Sales (TTM) -- 5.94 8.35
Price to Book (MRQ) 8.76 4.33 5.22
Price to Tangible Book (MRQ) -- 4.88 6.44
Price to Cash Flow (TTM) -- 22.89 25.88
% Owned Institutions 3.84 1.27 2.30

Dividends

  Company industry sector
Dividend Yield -- 1.61 1.52
Dividend Yield - 5 Year Avg -- 2.15 2.01
Dividend 5 Year Growth Rate -- 4.24 5.23
Payout Ratio(TTM) -- 43.87 41.36

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 8.46 9.76
Sales (TTM) vs TTM 1 Yr. Ago -- 6.42 7.57
Sales - 5 Yr. Growth Rate -- 9.88 10.22
EPS (MRQ) vs Qtr. 1 Yr. Ago 82.98 13.89 16.24
EPS (TTM) vs TTM 1 Yr. Ago 79.40 -- --
EPS - 5 Yr. Growth Rate -- 10.43 11.55
Capital Spending - 5 Yr. Growth Rate -4.18 14.59 14.75

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.39 2.42
Current Ratio (MRQ) 0.03 3.34 3.39
LT Debt to Equity (MRQ) 303.32 9.59 12.39
Total Debt to Equity (MRQ) 1,266.49 12.86 15.84
Interest Coverage (TTM) -1.72 44.40 38.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.27 54.79
Gross Margin - 5 Yr. Avg. -- 52.55 52.59
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -301,733.31 18.49 14.70
Operating Margin (TTM) -- 11.63 4.10
Operating Margin - 5 Yr. Avg. -343,366.69 14.28 9.99
Pre-Tax Margin (TTM) -- 12.01 4.83
Pre-Tax Margin - 5 Yr. Avg. -459,700.00 14.55 10.24
Net Profit Margin (TTM) -- 8.40 1.55
Net Profit Margin - 5 Yr. Avg. -436,680.91 10.89 6.54
Effective Tax Rate (TTM) -- 22.35 21.93
Effective Tax Rate - 5 Yr. Avg. -- 23.54 24.14

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 917,957,487 817,554,851
Net Income/Employee (TTM) -2,929,333 107,390,848 95,586,843
Receivable Turnover (TTM) -- 5.34 5.44
Inventory Turnover (TTM) -- 2.61 3.52
Asset Turnover (TTM) 0.00 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -97.89 11.18 10.73
Return on Assets - 5 Yr. Avg. -74.56 12.68 12.03
Return on Investment (TTM) -161.15 14.08 13.63
Return on Investment - 5 Yr. Avg. -109.15 16.60 15.76
Return on Equity (TTM) -430.75 15.71 15.39
Return on Equity - 5 Yr. Avg. -477.80 17.74 17.03
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 46.87 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Immune Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 3.84%
# of Holders: 17
Total Shares Held: 688,329
3 Mo. Net Change: 335,860
# New Positions: 5
# Closed Positions: 3
# Increased Positions: 8
# Reduced Positions: 3
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.